Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)
China · Delayed Price · Currency is CNY 11.93
-0.29 (-2.37%)
Nov 13, 2026, 3:04 PM CST
SHE:002365 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,155 | 783.17 | 838.81 | 972.89 | 1,462 | 1,565 |
Revenue Growth | 44.84% | -6.63% | -13.78% | -33.48% | -6.58% | 33.47% |
Gross Profit Gross Profit Growth | 309.71 | 131.08 | 166.02 | 250.52 | 471.32 | 353.73 |
Operating Income Operating Income Growth | 145.49 | -8.25 | 39.97 | 24.12 | 169.91 | 124.79 |
Net Income Net Income Growth | 111.43 | 22.49 | 61.77 | -12.31 | 140.16 | 107.78 |
Earnings Per Share EPS Growth | 0.39 | 0.08 | 0.21 | -0.04 | 0.48 | 0.38 |
EPS Growth | 341.93% | -62.93% | - | - | 26.66% | 2.75% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 494.97 | 634.73 | 662.17 | 883.25 | 783.23 |
Chemical Manufacturing Chemical Manufacturing Growth | 73.11 | 94.85 | 121.47 | 207.87 | 541.04 |
Health Foods Health Foods Growth | 210.21 | 103.76 | 156.77 | 313.13 | 195.66 |
Others Others Growth | 4.88 | 5.47 | 32.49 | 58.2 | 45.48 |
Total Total Growth | 783.17 | 838.81 | 972.89 | 1,462 | 1,565 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 813.3 | 918.47 | 920.57 | 956.27 | 832.22 | 547.53 |
Total Debt Total Debt Growth | 0.35 | 0.75 | 39.53 | 10.01 | 40.01 | 20.38 |
Net Cash (Debt) Net Cash Growth | 812.96 | 917.72 | 881.04 | 946.26 | 792.2 | 527.15 |
Net Cash Growth | -9.04% | 4.16% | -6.89% | 19.45% | 50.28% | -15.78% |
Net Cash Per Share Net Cash Per Share Growth | 2.81 | 3.17 | 2.99 | 3.21 | 2.69 | 1.84 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 123.51 | 139.08 | 105.71 | 221.2 | 387.28 | 101.81 |
Capital Expenditures CapEx Growth | -177.84 | -62.28 | -118.04 | -120.74 | -149.07 | -63.05 |
Free Cash Flow Free Cash Flow Growth | -54.33 | 76.81 | -12.33 | 100.46 | 238.21 | 38.76 |
Free Cash Flow Growth | - | - | - | -57.83% | 514.53% | -62.09% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 26.82% | 16.74% | 19.79% | 25.75% | 32.23% | 22.60% |
Operating Margin | 12.60% | -1.05% | 4.76% | 2.48% | 11.62% | 7.97% |
Pretax Margin | 11.46% | 1.26% | 8.45% | 0.62% | 10.47% | 8.29% |
Profit Margin | 9.65% | 2.87% | 7.36% | -1.27% | 9.58% | 6.88% |
FCF Margin | -4.71% | 9.81% | -1.47% | 10.32% | 16.29% | 2.48% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 0.100 | 0.100 | 0.100 | 0.100 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | - |
Dividend Yield | 0.84% | 0.67% | 1.25% | 1.02% | 0.95% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 30.96 | 191.79 | 37.67 | - | 22.08 | 28.97 |
Forward PE | - | 6.36 | 6.36 | 6.36 | 6.36 | 6.36 |
P/FCF Ratio | - | 56.17 | - | 28.69 | 12.99 | 80.55 |
PS Ratio | 3.01 | 5.51 | 2.77 | 2.96 | 2.12 | 2.00 |